The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 6th 2025
The FDA targets 7-hydroxymitragynine, a potent kratom derivative, as a controlled substance due to its opioid-like effects and rising health risks.
Management of Allergic Rhinitis Based on Patient Factors, Drug-Specific Characteristics
April 27th 2015Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, provides insight on the management of allergic rhinitis based on specific patient-related factors and drug-specific characteristics.
Watch
Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva
April 27th 2015Board concludes that approach grossly undervalues Mylan, includes low-quality, high-risk Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of delivering shareholder value.
Read More